Primary Care Services

209. Deputy Naoise Ó Cearúil asked the Minister for Health the steps being taken to restore staffing to the primary care children's assessment team in CHO7; the interim diagnostic pathways that are available to children who have been informed that no clinicians are currently available to carry out assessments; and if she will make a statement on the matter. [28368/26]

765. Deputy Ken O'Flynn asked the Minister for Health whether the Primary Care Reimbursement Service maintains product-specific data on rejected or unpaid pharmacy claims under the general medical services and drugs payment schemes; and if not, whether there are plans to introduce such data tracking mechanisms [28064/26]

766. Deputy Ken O'Flynn asked the Minister for Health whether any proportion of rejected or unpaid claims for salbutamol nebules in 2024 and 2025 can be disaggregated from general rejection categories; and if so, to provide the number and percentage of such claims. [28065/26]

767. Deputy Ken O'Flynn asked the Minister for Health to provide a detailed breakdown of the reasons for rejected or unpaid pharmacy claims under the general medical services scheme in 2024 and 2025, including the number of claims in each category and whether such categories are linked to specific medicines. [28066/26]

768. Deputy Ken O'Flynn asked the Minister for Health the oversight mechanisms that are in place to monitor rejection rates for commonly prescribed medicines under the general medical services scheme, including respiratory medications; and whether any review of rejection patterns has been conducted in the past three years. [28067/26]

769. Deputy Ken O'Flynn asked the Minister for Health whether any audit or validation exercise has been conducted on the accuracy and consistency of claim rejections by the Primary Care Reimbursement Service in 2024 or 2025; and if so, to provide details of the findings and any actions taken. [28068/26]

770. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive assesses the patient impact of rejected or unpaid pharmacy claims under the general medical services scheme; and if so, to outline the methodology used and any findings in relation to essential medicines. [28069/26]

771. Deputy Ken O'Flynn asked the Minister for Health whether any medicines were removed from, or had their reimbursement status altered within, the Primary Care Reimbursement Service systems in 2024 and 2025 which resulted in rejected claims; and to provide details of such medicines and the dates of change [28070/26]

772. Deputy Ken O'Flynn asked the Minister for Health the proportion of rejected or unpaid pharmacy claims under the general medical services scheme in 2024 and 2025 attributable to administrative or submission errors; and the measures in place to reduce such errors. [28071/26]

773. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any national database or registry recording clinical outcomes for patients who undergo procedures abroad under the treatment abroad scheme; if not, the reason no such system exists; and if she will outline any plans to establish one. [28074/26]

774. Deputy Ken O'Flynn asked the Minister for Health the mechanisms that are in place to ensure long-term follow-up care for patients undergoing procedures abroad under the treatment abroad scheme, and whether compliance with follow-up protocols is monitored or audited. [28076/26]

775. Deputy Ken O'Flynn asked the Minister for Health whether any audits have been conducted since 2020 on clinical outcomes or patient safety in respect of procedures funded under the treatment abroad scheme; if so, to provide details; if not, the reason none have been undertaken. [28077/26]

784. Deputy Ken O'Flynn asked the Minister for Health whether a formal requirement exists obliging clinicians to report clinical outcomes, complications, and follow-up care requirements to the Health Service Executive or her Department in respect of procedures funded under the treatment abroad scheme; and if not, whether she will introduce such a requirement. [28101/26]

785. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the Health Service Executive maintains any centralised or national system for the monitoring, recording, or analysis of clinical outcomes, complication rates, or long-term healthcare impacts for patients who receive procedures funded under the treatment abroad scheme; and if not, the reason for the absence of such a sy…

786. Deputy Ken O'Flynn asked the Minister for Health the mechanisms n place at a national level to evaluate patient safety, treatment effectiveness, and long-term health outcomes in respect of procedures funded under the treatment abroad scheme, in the absence of a centralised outcomes monitoring system. [28103/26]

787. Deputy Ken O'Flynn asked the Minister for Health whether any audits, reviews, or evaluations have been conducted by her Department or the Health Service Executive into clinical outcomes, complication rates, or follow-up care requirements arising from procedures funded under the treatment abroad scheme since 2020; and if so, to provide details including dates, scope, and findings. [28104/26]

789. Deputy Ken O'Flynn asked the Minister for Health the body or unit within her Department or the Health Service Executive holds responsibility at a national level for oversight of clinical outcomes, complication reporting, and long-term follow-up in respect of procedures funded under the Treatment Abroad Scheme. [28106/26]

835. Deputy Seamus Healy asked the Minister for Health the locations within CHO5 where HSE-employed audiologists are based within primary care services as of 17 February 2026; and if she will provide same figures as of 31 December 2023, in tabular form. [28175/26]

278. Deputy Louis O'Hara asked the Minister for Health if there is a child psychologist based in Athenry primary care centre; and if she will make a statement on the matter. [27735/26]

301. Deputy Holly Cairns asked the Minister for Health if CH04 is currently accepting adult ADHD assessments; the number of people on the waiting list; the average wait time; if CH04 currently is fully staffed; and if she will make a statement on the matter. [27859/26]

2651. Deputy Ken O'Flynn asked the Minister for Health to set out the current financial control and oversight mechanisms in place for primary care laboratory testing, including standard lipid profile testing, in circumstances where a national dataset on activity and cost is not held centrally; and if she will make a statement on the matter. [23704/26]

2652. Deputy Ken O'Flynn asked the Minister for Health to provide the total annual expenditure on primary care laboratory testing for each of the past five years, including any estimated or modelled figures used in the absence of a comprehensive national dataset; and if she will make a statement on the matter. [23705/26]

2653. Deputy Ken O'Flynn asked the Minister for Health whether any system is currently in place to attribute laboratory testing costs to individual service areas, patient cohorts, or primary care providers; and if not, the interim measures being used to support cost accountability pending the implementation of the National Laboratory Information System; and if she will make a statement on the matt…

2654. Deputy Ken O'Flynn asked the Minister for Health to detail any audits, reviews, or value-for-money assessments carried out in respect of primary care laboratory testing, including standard lipid profile tests, in the past five years; and if she will provide the findings of such assessments. [23707/26]

2655. Deputy Ken O'Flynn asked the Minister for Health whether any national or regional oversight mechanisms are in place to monitor patterns of laboratory test ordering in primary care, including safeguards against duplication or unnecessary testing; and if she will make a statement on the matter. [23708/26]